A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.
A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer. Cancer Biol Ther. 2006 Jul; 5(7):766-70.